Palette Life Sciences Announces FDA 510(k) Clearance for Barrigel® Rectal Spacer, Proven Safe and Effective at Minimizing the Harmful Long-Term Side Effects of Prostate Radiation Therapy - Palette Life Sciences

$ 16.99

4.8
(225)
In stock
Description

Groundbreaking technology introduces increased control to achieve optimal coverage proven to significantly reduce the risk of toxicity to the rectum SANTA BARBARA, CALIF. / STOCKHOLM, SWEDEN – June 9, 2022— Palette Life Sciences, a fully-integrated global life sciences company dedicated to improving patient outcomes, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of […]

SpaceOAR - Augmenix, Boston Scientific, and Conflicts of Interest

Prostate Cancer Radiation Therapy Recommendations in Response to

Per Langoe on LinkedIn: Another significant step forward for

Barrigel® Rectal Spacing

SpaceOAR - Augmenix, Boston Scientific, and Conflicts of Interest

Barrigel Spacer Minimize Prostate Radiation Side Effects

Vinny Devany on LinkedIn: Palette Life Sciences Announces FDA 510

Barrigel® Rectal Spacing

Salvage reirradiation for local failure of prostate cancer after

David Aguilar on LinkedIn: Palette Life Sciences Announces FDA 510

Salvage reirradiation for local failure of prostate cancer after